Belfast

Neurovalens raises £5M for clinical trials of its neurostimulation tech
By Sara Mageit | 07:58 am | July 22, 2020
The funding will aim to facilitate the company’s technology to treat conditions such as diabetes, insomnia, anxiety and obesity.